Loading insider details...
Latest Form 4 (Nov 3, 2026): Grant/Award of 42,500 TRAX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 3, 2026 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/Award | 42,500 | n/a |
| May 14, 2026 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/Award | 5,000 | n/a |
| Apr 23, 2026 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/Award | 45,700 | n/a |
| Jan 4, 2023 | Monte Rosa Therapeutics, Inc. (GLUE) | Grant/Award | 129,850 | n/a |
| Mar 2, 2022 | Monte Rosa Therapeutics, Inc. (GLUE) | Grant/Award | 111,700 | n/a |
| Jun 25, 2021 | Monte Rosa Therapeutics, Inc. (GLUE) | Grant/Award | 100,938 | n/a |